Hypoxia-preconditioned MSCs Have Superior Effect in Ameliorating Renal Function on Acute Renal Failure Animal Model
Author(s) -
Agung Putra,
Danis Pertiwi,
Meidourul Milla,
Ulfah Dian Indrayani,
Durotul Jannah,
Menik Sahariyani,
Setyo Trisnadi,
Joko Wahyu Wibowo
Publication year - 2019
Publication title -
open access macedonian journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.288
H-Index - 17
ISSN - 1857-9655
DOI - 10.3889/oamjms.2019.049
Subject(s) - medicine , creatinine , renal function , blood urea nitrogen , nephrotoxicity , urology , mesenchymal stem cell , dialysis , kidney , hypoxia (environmental) , pharmacology , endocrinology , pathology , chemistry , organic chemistry , oxygen
Acute renal failure (ARF) is a serious disease characterised by a rapid loss of renal functions due to nephrotoxic drug or ischemic insult. The clinical treatment approach such as dialysis techniques and continuous renal enhancement have grown rapidly during past decades. However, there is yet no significant effect in improving renal function. Hypoxia-preconditioned mesenchymal stem cells (HP-MSCs) have positive effects on the in vitro survival and stemness, in addition to angiogenic potential.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom